Next Article in Journal
Invasive Brain–Computer Interface for Communication: A Scoping Review
Previous Article in Journal
Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer’s Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Li et al. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672

1
State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, China
2
Laboratory of Molecular Neurobiology, Academy of Biology and Biotechnology, Southern Federal University, Stachki Ave. 194/1, 344090 Rostov-on-Don, Russia
*
Authors to whom correspondence should be addressed.
Brain Sci. 2025, 15(4), 335; https://doi.org/10.3390/brainsci15040335
Submission received: 19 February 2025 / Accepted: 20 February 2025 / Published: 24 March 2025
Text Correction
In the original publication [1], a correction has been made to Section 2, the last paragraph, the fourth sentence. The updated sentence is as follows:
On the contrary, although SIRT2 can directly bind with and deacetylate FOXO3a upon caloric restriction and oxidative stress.
Citation updated
The original citation [80] has been removed. With this correction, the order of some references has been adjusted accordingly.
References
Original reference [81] has been replaced with the following reference:
81. Wang, F.; Nguyen, M.; Qin, F.X.; Tong, Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007, 6, 505–514.
The authors state that the scientific conclusions are unaffected. These correction were approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Li, Y.; Gu, Z.; Lin, S.; Chen, L.; Dzreyan, V.; Eid, M.; Demyanenko, S.; He, B. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, Y.; Gu, Z.; Lin, S.; Chen, L.; Dzreyan, V.; Eid, M.; Demyanenko, S.; He, B. Correction: Li et al. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672. Brain Sci. 2025, 15, 335. https://doi.org/10.3390/brainsci15040335

AMA Style

Li Y, Gu Z, Lin S, Chen L, Dzreyan V, Eid M, Demyanenko S, He B. Correction: Li et al. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672. Brain Sciences. 2025; 15(4):335. https://doi.org/10.3390/brainsci15040335

Chicago/Turabian Style

Li, Yan, Zhicheng Gu, Shuxian Lin, Lei Chen, Valentina Dzreyan, Moez Eid, Svetlana Demyanenko, and Bin He. 2025. "Correction: Li et al. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672" Brain Sciences 15, no. 4: 335. https://doi.org/10.3390/brainsci15040335

APA Style

Li, Y., Gu, Z., Lin, S., Chen, L., Dzreyan, V., Eid, M., Demyanenko, S., & He, B. (2025). Correction: Li et al. Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sci. 2022, 12, 672. Brain Sciences, 15(4), 335. https://doi.org/10.3390/brainsci15040335

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop